• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

大麻素受体对大鼠脑膜中鸟苷-5'-O-(3-[35S]硫代)三磷酸结合的刺激作用。

Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes.

作者信息

Selley D E, Stark S, Sim L J, Childers S R

机构信息

Department of Physiology and Pharmacology, Bowman Gray School of Medicine, Winston-Salem, NC 27157, USA.

出版信息

Life Sci. 1996;59(8):659-68. doi: 10.1016/0024-3205(96)00347-5.

DOI:10.1016/0024-3205(96)00347-5
PMID:8761016
Abstract

Cannabinoid receptors belong to the class of G-protein-coupled receptors which inhibit adenylyl cyclase. Coupling of receptors to G-proteins can be assessed by the ability of agonists to stimulate guanosine-5'-O-(3-[35S]thio)triphosphate ([35S]GTP gamma S) binding in the presence of excess GDP. The present study examined the effect of cannabinoid agonists on [35S]GTP gamma S binding in rat brain membranes. Assays were conducted with 0.05 nM [35S]GTP gamma S, incubated with rat cerebellar membranes, 1-30 microM GDP and the cannabinoid agonist WIN 55212-2. Results showed that the ability of WIN 55212-2 to stimulate [35S]GTP gamma S binding increased with increasing concentrations of GDP, with 10-30 microM GDP providing approximately 150-200% stimulation by the cannabinoid agonist. The pharmacology of cannabinoid agonist stimulation of [35S]GTP gamma S binding paralleled that of previously reported receptor binding and adenylyl cyclase assays, and agonist stimulation of [35S]GTP gamma S binding was blocked by the cannabinoid antagonist SR141716A. Brain regional studies revealed widespread stimulation of [35S]GTP gamma S binding by WIN 55212-2 in a number of brain areas, consistent with in vitro [35S]GTP gamma S autoradiography. These results demonstrate that [35S]GTP gamma S binding in the presence of excess GDP is an effective measure of cannabinoid receptor coupling to G-proteins in brain membranes.

摘要

大麻素受体属于抑制腺苷酸环化酶的G蛋白偶联受体类别。受体与G蛋白的偶联可通过激动剂在过量GDP存在下刺激鸟苷-5'-O-(3-[35S]硫代)三磷酸([35S]GTPγS)结合的能力来评估。本研究检测了大麻素激动剂对大鼠脑膜中[35S]GTPγS结合的影响。实验采用0.05 nM [35S]GTPγS,与大鼠小脑膜、1-30 μM GDP以及大麻素激动剂WIN 55212-2一起孵育。结果显示,WIN 55212-2刺激[35S]GTPγS结合的能力随GDP浓度增加而增强,10-30 μM GDP时大麻素激动剂提供约150-200%的刺激。大麻素激动剂刺激[35S]GTPγS结合的药理学与先前报道的受体结合和腺苷酸环化酶检测结果相似,且大麻素拮抗剂SR141716A可阻断激动剂对[35S]GTPγS结合的刺激。脑区研究显示,WIN 55212-2在多个脑区广泛刺激[35S]GTPγS结合,这与体外[35S]GTPγS放射自显影结果一致。这些结果表明,在过量GDP存在下的[35S]GTPγS结合是衡量大麻素受体与脑膜中G蛋白偶联的有效指标。

相似文献

1
Cannabinoid receptor stimulation of guanosine-5'-O-(3-[35S]thio)triphosphate binding in rat brain membranes.大麻素受体对大鼠脑膜中鸟苷-5'-O-(3-[35S]硫代)三磷酸结合的刺激作用。
Life Sci. 1996;59(8):659-68. doi: 10.1016/0024-3205(96)00347-5.
2
In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5'-[gamma-[35S]thio]-triphosphate binding.通过激动剂刺激的鸟苷5'-[γ-[35S]硫代]-三磷酸结合对大鼠脑中受体激活的G蛋白进行体外放射自显影。
Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7242-6. doi: 10.1073/pnas.92.16.7242.
3
Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity.大麻素受体激动剂刺激[35S]GTPγS与大鼠小脑膜结合的效能与激动剂诱导的GDP亲和力降低相关。
J Biol Chem. 1998 Jul 3;273(27):16865-73. doi: 10.1074/jbc.273.27.16865.
4
Evaluation of cannabinoid receptor agonists and antagonists using the guanosine-5'-O-(3-[35S]thio)-triphosphate binding assay in rat cerebellar membranes.使用鸟苷-5'-O-(3-[35S]硫代)-三磷酸结合试验在大鼠小脑膜中评估大麻素受体激动剂和拮抗剂。
J Pharmacol Exp Ther. 1998 May;285(2):553-60.
5
Autoradiographic analysis of cannabinoid receptor binding and cannabinoid agonist-stimulated [35S]GTP gamma S binding in morphine-dependent mice.对吗啡依赖小鼠中大麻素受体结合及大麻素激动剂刺激的[35S]GTPγS结合的放射自显影分析。
Drug Alcohol Depend. 1998 May 1;50(3):241-9. doi: 10.1016/s0376-8716(98)00036-2.
6
Cannabinoid receptor and WIN-55,212-2-stimulated [35S]GTP gamma S binding and cannabinoid receptor mRNA levels in the basal ganglia and the cerebellum of adult male rats chronically exposed to delta 9-tetrahydrocannabinol.成年雄性大鼠长期暴露于Δ⁹-四氢大麻酚后,其基底神经节和小脑中的大麻素受体、WIN-55,212-2刺激的[³⁵S]GTPγS结合以及大麻素受体mRNA水平
J Mol Neurosci. 1998 Oct;11(2):109-19. doi: 10.1385/JMN:11:2:109.
7
Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum.大鼠纹状体中μ-阿片受体、δ-阿片受体及大麻素受体对G蛋白激活作用的差异。
Eur J Pharmacol. 1996 Jun 20;307(1):97-105. doi: 10.1016/0014-2999(96)00211-7.
8
AM630 antagonism of cannabinoid-stimulated [35S]GTP gamma S binding in the mouse brain.
Eur J Pharmacol. 1997 Feb 19;321(1):R1-3. doi: 10.1016/s0014-2999(97)00047-2.
9
Interaction of brain cannabinoid receptors with guanine nucleotide binding protein: a radioligand binding study.脑大麻素受体与鸟嘌呤核苷酸结合蛋白的相互作用:一项放射性配体结合研究。
Biochem Pharmacol. 1997 Dec 1;54(11):1267-70. doi: 10.1016/s0006-2952(97)00384-5.
10
Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain.δ9-四氢大麻酚长期治疗对大鼠脑中大麻素刺激的[35S]GTPγS放射自显影的影响。
J Neurosci. 1996 Dec 15;16(24):8057-66. doi: 10.1523/JNEUROSCI.16-24-08057.1996.

引用本文的文献

1
Development of Novel Neuroprotective Agents Targeting GPCR Using in Vitro Assays.利用体外试验开发靶向GPCR的新型神经保护剂
Methods Mol Biol. 2025;2899:339-366. doi: 10.1007/978-1-0716-4386-0_22.
2
Chronic phenmetrazine treatment promotes D dopaminergic and α2-adrenergic receptor desensitization and alters phosphorylation of signaling proteins and local cerebral glucose metabolism in the rat brain.长期服用苯甲曲秦可促进大鼠脑内D多巴胺能和α2肾上腺素能受体脱敏,并改变信号蛋白的磷酸化及局部脑葡萄糖代谢。
Brain Res. 2021 Feb 23;1761:147387. doi: 10.1016/j.brainres.2021.147387.
3
The endocannabinoid system - current implications for drug development.
内源性大麻素系统 - 对药物开发的当前影响。
J Intern Med. 2021 Jul;290(1):2-26. doi: 10.1111/joim.13229. Epub 2021 Jan 29.
4
Stratification of Cannabinoid 1 Receptor (CB1R) Agonist Efficacy: Manipulation of CB1R Density through Use of Transgenic Mice Reveals Congruence between In Vivo and In Vitro Assays.大麻素1受体(CB1R)激动剂功效的分层:通过使用转基因小鼠对CB1R密度进行调控揭示了体内和体外试验之间的一致性。
J Pharmacol Exp Ther. 2016 Nov;359(2):329-339. doi: 10.1124/jpet.116.233163. Epub 2016 Aug 17.
5
Pharmacological characterization of repeated administration of the first generation abused synthetic cannabinoid CP47,497.第一代滥用合成大麻素CP47,497重复给药的药理学特征
J Basic Clin Physiol Pharmacol. 2016 May 1;27(3):217-28. doi: 10.1515/jbcpp-2015-0118.
6
3-Substituted pyrazole analogs of the cannabinoid type 1 (CB₁) receptor antagonist rimonabant: cannabinoid agonist-like effects in mice via non-CB₁, non-CB₂ mechanism.3-取代吡唑类大麻素 1 型受体(CB₁)拮抗剂利莫那班类似物:通过非 CB₁、非 CB₂机制在小鼠中产生类大麻素激动剂样作用。
J Pharmacol Exp Ther. 2012 Feb;340(2):433-44. doi: 10.1124/jpet.111.187815. Epub 2011 Nov 15.
7
Endocannabinoid tone versus constitutive activity of cannabinoid receptors.内源性大麻素基调与大麻素受体的组成活性。
Br J Pharmacol. 2011 Aug;163(7):1329-43. doi: 10.1111/j.1476-5381.2011.01364.x.
8
Structural and pharmacological analysis of O-2050, a putative neutral cannabinoid CB(1) receptor antagonist.O-2050 结构和药理学分析,一种假定的中性大麻素 CB(1)受体拮抗剂。
Eur J Pharmacol. 2011 Jan 25;651(1-3):96-105. doi: 10.1016/j.ejphar.2010.10.085. Epub 2010 Nov 27.
9
1-Bromo-3-(1',1'-dimethylalkyl)-1-deoxy-Δ(8)-tetrahydrocannabinols: New selective ligands for the cannabinoid CB(2) receptor.1-溴-3-(1',1'-二甲基烷基)-1-去氧-Δ(8)-四氢大麻醇:大麻素 CB(2)受体的新型选择性配体。
Bioorg Med Chem. 2010 Nov 15;18(22):7809-15. doi: 10.1016/j.bmc.2010.09.061. Epub 2010 Sep 29.
10
Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents.κ 阿片受体介导强效致幻剂 salvinorin A 对啮齿类动物的大麻素效应。
Psychopharmacology (Berl). 2010 Jun;210(2):275-84. doi: 10.1007/s00213-010-1827-6. Epub 2010 Mar 31.